Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 2, 2013, Pages 208-212

  Kanda, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN; NATALIZUMAB;

BLOOD BRAIN BARRIER; CELL IMMORTALIZATION; CELL LINE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CYTOLOGY; DIABETIC NEUROPATHY; ENDOTHELIUM CELL; GUILLAIN BARRE SYNDROME; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOTOR NEUROPATHY; MULTIPLE SCLEROSIS; NONHUMAN; PARENCHYMA; PATHOGENESIS; PERIPHERAL NERVE; POEMS SYNDROME; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 84872678428     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302312     Document Type: Review

References (51)

1. Mizisin AP, Weerasuriya A. Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol 2011;121:291-312.
2. Bell M, Weddell A. A descriptive study of the blood vessels of the sciatic nerve of the rat, man and other mammals. Brain 1984;107:871-98.
3. Sano Y, Shimizu F, Nakayama H, et al. Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells. Cell Struct Funct 2007;32:139-47.
4. Sixt M, Engelhardt B, Pausch F, et al. Endothelial cell laminin isoforms, laminin 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 2001;153:933-46.
5. Arvidson B. Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve. Acta Neuropathol 1977;37:35-41.
6. Poduslo J, Curran G, Berg C. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 1994;91:5705-9.
7. Cucullo L, Couraud PO, Weksler B, et al. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 2008;28:312-28.
8. Sano Y, Shimizu F, Abe M, et al. Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function. J Cell Physiol 2010;225:519-28.
9. Argall KG, Armati PJ, Pollard JD. A method for the isolation and culture of rat peripheral nerve vascular endothelial cells. Mol Cell Neurosci 1994;5:413-17.
10. Kanda T, Iwasaki T, Yamawaki M, et al. Isolation and culture of bovine endothelial cells of endoneurial origin. J Neurosci Res 1997;49:769-77.
11. Kanda T, Iwasaki T, Yamawaki M, et al. Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model. Neurology 2000;55:585-7.
12. Kanda T, Yamawaki M, Mizusawa H. Sera from Guillain-Barre patients enhance leakage in blood-nerve barrier model. Neurology 2003;60:301-6.
13. Shimizu F, Sano Y, Maeda T, et al. Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells. J Cell Physiol 2008;217:388-99.
14. Shimizu F, Sano Y, Haruki H, et al. Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-beta and vascular endothelial growth factor (VEGF) by pericytes. Diabetologia 2011;54:1517-26.
15. Kashiwamura Y, Sano Y, Abe M, et al. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5. Neurochem Res 2011;36:849-55.
16. Shimizu F, Sano Y, Abe MA, et al. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J Cell Physiol 2011;226:255-66.
17. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993;123:1777-88.
18. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003;161:653-60.
19. Yeung D, Manias JL, Stewart DJ, et al. Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown. Acta Neuropathol 2008;115:635-42.
20. Shimizu F, Sano Y, Saito K, et al. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res 2012;37:401-9.
21. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011;686:49-68.
22. Dore-Duffy P, Katychev A, Wang X, et al. CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 2006;26:613-24.
23. Jacobs JM, Macfarlane RM, Cavanagh JB. Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. J Neurol Sci 1976;29:95-107.
24. Burkel WE. The histological fine structure of perineurium. Anat Rec 1967;158:177-89.
25. Brown WF, Snow R. Patterns and severity of conduction abnormalities in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1991;54:768-74.
26. Kuwabara S, Ogawara K, Misawa S, et al. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002;72:37-42.
27. Ritchie TC, Fabian RH, Choate JV, et al. Axonal transport of monoclonal antibodies. J Neurosci 1986;6:1177-84.
28. Fewou SN, Rupp A, Nickolay LE, et al. Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J Clin Invest 2012;122:1037-51.
29. Previtali SC, Archelos JJ, Hartung HP. Expression of integrins in experimental autoimmune neuritis and Guillain-Barre syndrome. Ann Neurol 1998;44:611-21.
30. Kieseier BC, Tani M, Mahad D, et al. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 2002;125:823-34.
31. Kieseier BC, Clements JM, Pischel HB, et al. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann Neurol 1998;43:427-34.
32. Kaji R, Oka N, Tsuji T, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993;33:152-8.
33. Lach B, Rippstein P, Atack D, et al. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta Neuropathol 1993;85:298-307.
34. Kanda T, Yamawaki M, Iwasaki T, et al. Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy. Neurology 2000;54:1459-64.
35. Meier C, Roberts K, Steck A, et al. Polyneuropathy in Waldenström's macroglobulinemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol 1984;64:297-307.
36. Kanda T, Usui S, Beppu H, et al. Blood-nerve barrier in IgM paraproteinemic neuropathy: a clinicopathologic assessment. Acta Neuropathol 1998;95:184-92.
37. Kanda T, Yoshino H, Ariga T, et al. Glycosphingolipid antigens in cultured microvascular bovine endothelial cells; sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J Cell Biol 1994;126:235-46.
38. Kanda T, Numata Y, Mizusawa H. Chronic inflammatory demyelinating polyneuropathy; decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry 2004;75:765-9.
39. Gironi M, Saresella M, Marventano I, et al. Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy. Muscle Nerve 2010;42:864-70.
40. Saida K, Kawakami H, Ohta M, et al. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve 1997;20:486-92.
41. Adams D, Said G. Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome. J Neurol Neurosurg Psychiatry 1998;64:809-12.
42. Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005;128:1911-20.
43. Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2012;83:476-9.
44. Mauermann ML, Sorenson EJ, Dispenzieri A, et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry 2012;83:480-6.
45. Powell HC, Rosoff J, Myers RR. Microangiopathy in human diabetic neuropathy. Acta Neuropathol 1985;68:295-305.
46. Giannini C, Dyck P. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 1995;37:498-504.
47. Wu C, Ivars F, Anderson P, et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med 2009;15:519-27.
48. Engelhardt B. T cell migration into the central nervous system during health and disease: different molecular keys allow access to different central nervous system compartments. Clin Exp Neuroimmunol 2010;1:79-93.
49. Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-89.
50. Enders U, Lobb R, Pepinsky RB, et al. The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat. Brain 1998;121(Pt 7):1257-66.
51. Wolf C, Menge T, Stenner MP, et al. Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2010;67:881-3.